High incidence of meropenem resistance among alpha-hemolytic streptococci in children with cancer

Pediatr Int. 2009 Feb;51(1):103-6. doi: 10.1111/j.1442-200X.2008.02663.x.

Abstract

Background: Infections caused by antibiotics-resistant Gram-positive bacteria have been reported from many pediatric hematology-oncology centers.

Methods: The susceptibility profiles to meropenem, piperacillin, and vancomycin among oral flora isolates of alpha-hemolytic streptococci (AHS) obtained from six children with cancer who received several empirical therapies (ET) against febrile neutropenia, were investigated.

Results: Meropenem minimum inhibitory concentration (MIC) of AHS isolated from ET patients was 2.167 +/- 0.258 microg/mL (mean +/- SD), which was significantly higher than the MIC of AHS isolated from control groups. Intriguingly, AHS isolated approximately 6 months after hospital discharge indicated recovery of susceptibility to meropenem.

Conclusions: AHS isolates from neutropenic children with cancer should be checked for antibiotic susceptibility, even against carbapenems.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / pharmacology*
  • Child
  • Child, Preschool
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Infant
  • Infant, Newborn
  • Meropenem
  • Neoplasms / complications*
  • Neutropenia / complications
  • Neutropenia / microbiology*
  • Streptococcal Infections / complications
  • Streptococcal Infections / microbiology*
  • Streptococcus / drug effects
  • Streptococcus / isolation & purification*
  • Thienamycins / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Thienamycins
  • Meropenem